NCT00651560已完成3 期
Vytorin As Strategy To Reduce Dislipidemia In Adults
适应症
相关药物
试验速览
- 阶段
- 3 期
- 状态
- 已完成
- 入组人数
- 167
- 主要终点
- Evaluate the hypolipidemic effect of Vytorin after 4 weeks treatment in adult patients with mix dislipidemia to reduce the cardiovascular risk and achieve the ATP-III goals.
研究概览
简要总结
This study is intended to allow physicians to check the superior clinical efficacy of Vytorin compared to atorvastatin, as the most adequate therapy using the ATP-III goals achievement and cardiovascular risk reduction in adult patients with dislipidemia.
研究设计
- 研究类型
- Interventional
- 分配方式
- Non Randomized
- 干预模型
- Single Group
- 主要目的
- Treatment
- 盲法
- None
入排标准
- 年龄范围
- 18 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Patients Who Voluntary Accept To Participate In The Study After Been Informed By The Doctor And Signed The Informed Consent Form.
排除标准
- •Any Another Kind Of Contraindication For Use Of Statins
- •Hypersensitivity To Any Of The Active Ingredients
- •Increased Serum Hepatic Enzymes (Over 3 Times Only)
- •Patients With Severe Hepatic Insufficiency
- •Women who are Pregnant or Potentially Pregnant
结局指标
主要结局
Evaluate the hypolipidemic effect of Vytorin after 4 weeks treatment in adult patients with mix dislipidemia to reduce the cardiovascular risk and achieve the ATP-III goals.
时间窗: After 4 weeks treatment
次要结局
- To determine the capability of Vytorin to allow adults patients with dislipidemia and previously treated with atorvastatin to get further reduction of the cardiovascular risk and to achieve the ATP-III goals.(After 4 weeks treatment)
研究者
相似试验
终止
2 期
Atorvastatin to Prevent Avascular Necrosis of Bone in Steroid Treated Exacerbated Systemic Lupus ErythematosusAvascular NecrosisNCT00412841NYU Langone Health43
已完成
3 期
Vitamin D & Levothyroxine Combination Versus Levothyroxine on Lipid Profile in HypothyroidismHypothyroidism PrimaryLipid DisorderDyslipidemiasNCT06276205King Edward Medical University62
已完成
4 期
Vascular and Metabolic Effects of VytorinHypercholesterolemiaNCT01660945Gachon University Gil Medical Center204
已完成
4 期
Prevention of Lipoatrophy in Patients Treated With Lopinavir/Ritonavir in Monotherapy Versus ZDV + 3TC + ABCHIV InfectionHIV InfectionsNCT00865475Fundacion SEIMC-GESIDA38
Unknown
3 期
Vitamin D Supplementation for Treatment of DyslipidemiaDyslipidemiasNCT03133975Mansoura University30